| Product Code: ETC6166541 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Armenia Pharmacogenomics Market Overview |
3.1 Armenia Country Macro Economic Indicators |
3.2 Armenia Pharmacogenomics Market Revenues & Volume, 2021 & 2031F |
3.3 Armenia Pharmacogenomics Market - Industry Life Cycle |
3.4 Armenia Pharmacogenomics Market - Porter's Five Forces |
3.5 Armenia Pharmacogenomics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Armenia Pharmacogenomics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Armenia Pharmacogenomics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Armenia Pharmacogenomics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing adoption of personalized medicine in Armenia |
4.2.2 Growing prevalence of chronic diseases requiring personalized treatment |
4.2.3 Government initiatives promoting pharmacogenomics research and implementation |
4.3 Market Restraints |
4.3.1 Limited awareness and understanding of pharmacogenomics among healthcare professionals and patients |
4.3.2 High costs associated with pharmacogenomic testing and treatments |
4.3.3 Lack of standardized guidelines and regulations for pharmacogenomics in Armenia |
5 Armenia Pharmacogenomics Market Trends |
6 Armenia Pharmacogenomics Market, By Types |
6.1 Armenia Pharmacogenomics Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Armenia Pharmacogenomics Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Armenia Pharmacogenomics Market Revenues & Volume, By Polymerase Chain Reaction, 2021- 2031F |
6.1.4 Armenia Pharmacogenomics Market Revenues & Volume, By Microarray, 2021- 2031F |
6.1.5 Armenia Pharmacogenomics Market Revenues & Volume, By DNA Sequencing, 2021- 2031F |
6.1.6 Armenia Pharmacogenomics Market Revenues & Volume, By Mass Spectrometry, 2021- 2031F |
6.1.7 Armenia Pharmacogenomics Market Revenues & Volume, By Electrophoresis, 2021- 2031F |
6.1.8 Armenia Pharmacogenomics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Armenia Pharmacogenomics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Armenia Pharmacogenomics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 Armenia Pharmacogenomics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.4 Armenia Pharmacogenomics Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.5 Armenia Pharmacogenomics Market Revenues & Volume, By Neurological Diseases, 2021- 2031F |
6.2.6 Armenia Pharmacogenomics Market Revenues & Volume, By Psychiatry, 2021- 2031F |
6.2.7 Armenia Pharmacogenomics Market Revenues & Volume, By Pain Management, 2021- 2031F |
6.3 Armenia Pharmacogenomics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Armenia Pharmacogenomics Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.3.3 Armenia Pharmacogenomics Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F |
7 Armenia Pharmacogenomics Market Import-Export Trade Statistics |
7.1 Armenia Pharmacogenomics Market Export to Major Countries |
7.2 Armenia Pharmacogenomics Market Imports from Major Countries |
8 Armenia Pharmacogenomics Market Key Performance Indicators |
8.1 Number of healthcare facilities offering pharmacogenomic testing and services in Armenia |
8.2 Rate of integration of pharmacogenomics in medical education curriculum |
8.3 Percentage of healthcare professionals trained in pharmacogenomics |
8.4 Number of research studies and publications related to pharmacogenomics in Armenia |
9 Armenia Pharmacogenomics Market - Opportunity Assessment |
9.1 Armenia Pharmacogenomics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Armenia Pharmacogenomics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Armenia Pharmacogenomics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Armenia Pharmacogenomics Market - Competitive Landscape |
10.1 Armenia Pharmacogenomics Market Revenue Share, By Companies, 2024 |
10.2 Armenia Pharmacogenomics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here